Company RavenQuest BioMed Inc. Canadian Securities Exchange
Equities
RQB
CA7543871080
Business Support Services
Business Summary
Sales per Business
CAD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Consulting
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +1,018.58% |
Sales per region
CAD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +1,018.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 19-11-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 19-11-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 123,913,559 | 110,882,259 ( 89.48 %) | 0 | 89.48 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
6,764,945 | 8.65% | 520,901 $ |
Company contact information
RavenQuest BioMed, Inc.
580 Hornby Street Suite 780
V6C 3B6, Vancouver
+877-282-1586
![address RavenQuest BioMed Inc.(RQB)](https://cdn.zonebourse.com/static/address/38481075.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+9.35% | 7.55B | |
-26.78% | 3.26B | |
+6.98% | 1.63B | |
-20.82% | 954M | |
+1.69% | 706M | |
-10.76% | 663M | |
-5.53% | 605M | |
-9.51% | 590M | |
-5.29% | 546M |